Rescuing mutant CFTR: a multi-task approach to a better outcome in treating cystic fibrosis.

Abstract excerpt

Correcting multiple defects of mutant CFTR with small molecule compounds has been the goal of an increasing number of recent Cystic Fibrosis (CF) drug discovery programmes. However, the mechanism of action (MoA) by which these molecules restore mutant CFTR is still poorly understood, in particular of CFTR correctors, i.e., compounds rescuing to the cells surface the most prevalent mutant in CF...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cold Temperature
• Share to Cystic Fibrosis
• Share to Cystic Fibrosis Transmembrane Conductance Regulator